Journal
CURRENT INFECTIOUS DISEASE REPORTS
Volume 14, Issue 6, Pages 668-675Publisher
SPRINGER
DOI: 10.1007/s11908-012-0296-y
Keywords
Solid organ transplantation; Hematopoietic stem cell transplantation; Mucormycosis; Health-care-associated infection; Pneumocystis pneumonia
Categories
Funding
- patient association Vaincre la mucoviscidose
- MSD, Astellas
- Gilead Sciences
- Pfizer
Ask authors/readers for more resources
Invasive fungal infections continue to be a major cause of morbidity and mortality in severely immunocompromised transplant patients. Although Candida spp. and Aspergillus spp. represent the majority of identified pathogens, other fungi have become increasingly prevalent among this patient population. Diagnosis and treatment of invasive fungal infections remain a challenge in transplant medicine despite recent major advances. In this review, we will emphasize emerging topics in invasive fungal infections in transplantations that occurred in 2011-2012. The current literature was reviewed to synthesize new trends in epidemiology, recent outbreaks, clinical findings, and advances in diagnostic and therapeutic resources.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available